CXBladder has midkine as one of the biomarkers and royalties of around 3 to 4% are due to CDY on any sale.
This announcement today validates the use of midkine in a clinical setting in a diagnostic test.
A massive door has been opened as this wont go unnoticed by the likes of Johns Hopkins, CMS and multiple other users in the US and worldwide.
Kaiser Permanente, page-13
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable